Cargando…
Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
The combination of immune-checkpoint blockade (ICB) and lenvatinib has demonstrated robust clinical effects that are superior to those of monotherapies, but the synergistic anti-tumor mechanisms remain unclear. Exploring the synergistic molecular mechanisms and early identifying potential applicatio...
Autores principales: | Lu, Yuting, Jin, Jiangtao, Du, Qi, Hu, Min, Wei, Yuhan, Wang, Miao, Li, Hongzhong, Li, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458708/ https://www.ncbi.nlm.nih.gov/pubmed/34568339 http://dx.doi.org/10.3389/fcell.2021.730240 |
Ejemplares similares
-
Single Cell Multi-Omics Technology: Methodology and Application
por: Hu, Youjin, et al.
Publicado: (2018) -
The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
por: Liu, Xiangzheng, et al.
Publicado: (2021) -
Multi-Omics Uncover Neonatal Cecal Cell Development Potentials
por: Chen, Liang, et al.
Publicado: (2022) -
Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021) -
Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
por: Tu, Can, et al.
Publicado: (2021)